UNM
70
3
SLB
44
3
SJM
19
2
DAL
61
3
WMB
60
2
LB
19
3
BBY
46
-2
NVDA
57
5
NI
67
2
JCI
42
-2
HPE
44
-4
PGR
49
4
MAC
51
-2
GM
57
2
PAYX
39
3
UNH
44
2
AON
28
2
AIV
37
-3
HAL
30
-10
C
51
3
UNM
70
3
SLB
44
3
SJM
19
2
DAL
61
3
WMB
60
2
LB
19
3
BBY
46
-2
NVDA
57
5
NI
67
2
JCI
42
-2
HPE
44
-4
PGR
49
4
MAC
51
-2
GM
57
2
PAYX
39
3
UNH
44
2
AON
28
2
AIV
37
-3
HAL
30
-10
C
51
3
Financhill
Back

Chugai Pharmaceutical 10K Form

Buy
51

CHGCF
Chugai Pharmaceutical

Last Price:
$41.75
Seasonality Move:
-0.21%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CHGCF News And Ratings

See the #1 stock for the next 7 days that we like better than CHGCF

CHGCF Financial Statistics

Sales & Book Value

Annual Sales: $7.9B
Cash Flow: $750M
Price / Cash Flow: 28.24
Annual Sales: $7.67
Price / Book: 5.41

Profitability

EPS (TTM): 1.56390
Net Income (TTM): $2.6B
Gross Margin: $5B
Return on Equity: 22.92%
Return on Assets: 19.59%

Chugai Pharmaceutical Earnings Forecast

Key Chugai Pharmaceutical Financial Ratios

  • The Gross Profit Margin over the past 21 years for CHGCF is 62.81%.
  • The Selling, General & Administrative Expenses for CHGCF have been equal to 10.13% of Gross Profit Margin.
  • The Research & Development expenses have been 15.73% of Revenue.
  • The Interest Expense is 0.01% of Operating Income.
  • The Net Earning history of CHGCF is 29.29% of Total Revenues.
  • Per Share Earnings over the last 21 years have been positive in 13 years.

Chugai Pharmaceutical Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: CHGCF
Website: chugai-pharm.co.jp

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 5.89
Quick Ratio: 4.67

Price-to-Earnings

Trailing P/E Ratio: 29.43
Forward P/E Ratio: 0

CHGCF Technical Analysis vs Fundamental Analysis

Buy
51
Chugai Pharmaceutical (CHGCF) is a Buy

Is Chugai Pharmaceutical a Buy or a Sell?